Skip to main content
. 2011 Mar 11;300(6):H1990–H1996. doi: 10.1152/ajpheart.01267.2010

Fig. 2.

Fig. 2.

Effects of 1 wk oral administration of cis-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (AUCB) on mean arterial blood pressure (MAP, A) and heart rate (B). *P < 0.05 compared with vehicle-treated WKY or SHR of the same strain, n = 6–8.